A facile route to heterotelechelic polymer prodrug nanoparticles for imaging, drug delivery and combination therapy

J Control Release. 2018 Sep 28:286:425-438. doi: 10.1016/j.jconrel.2018.08.013. Epub 2018 Aug 9.
No abstract available

Keywords: Cancer; Combination therapy; Drug delivery; Nanoparticles; Polymer; Prodrug.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / drug therapy*
  • Combined Modality Therapy
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Deoxycytidine / chemistry
  • Deoxycytidine / pharmacology
  • Drug Delivery Systems
  • Female
  • Fluorescent Dyes / administration & dosage*
  • Fluorescent Dyes / chemistry
  • Fluorescent Dyes / pharmacology
  • Gemcitabine
  • Humans
  • MCF-7 Cells
  • Nanoparticles / administration & dosage*
  • Nanoparticles / chemistry
  • Optical Imaging
  • Polymers / administration & dosage*
  • Polymers / chemistry
  • Polymers / pharmacology
  • Prodrugs / administration & dosage*
  • Prodrugs / chemistry
  • Prodrugs / pharmacology
  • Rhodamines / administration & dosage
  • Rhodamines / chemistry
  • Rhodamines / pharmacology

Substances

  • Antineoplastic Agents
  • Fluorescent Dyes
  • Polymers
  • Prodrugs
  • Rhodamines
  • Deoxycytidine
  • Gemcitabine